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ABSTRACT 
       Ionization radiation caused to incidence of complications in the exposed organs. In prostate radiotherapy, 
rectum and bladder have been radiated unwantedly and indicated some complications during and after 
treatment. The purpose of present study is to consider and to compare clinical complications of rectum and 
bladder in custom block and MLC for 3- D conformal radiotherapy, in order to determine if both treatments 
differ with respect to creating radiation protection, subsequently in the incidence of complications. In this 
respect, 72 patients with prostate cancer classified into two arms, above 60 years without the history of 
previous radiotherapy, hormone therapy and surgery, were selected randomly in October 2014. In one arm, 
patients were treated with block 3- D conformal radiotherapy, and in second arm with MLC outbound 
technique for 3- D radiotherapy. Rectal and bladder clinical complications were recorded before, during (at 
the end of 10 treatment sessions), 3 and 6 months after treatment then compared based on tables (RTOG/ 
LENT).Obtained results showed that patients had a significant difference in such complications as urinary 
frequency after 10 treatment sessions, 3 months after treatment (p<0.02 and p<0.04, respectively)   Also, 
patients had a significant difference in regard to dysuria at the end of treatment (p<0.02). In both arms, 
patients had a significant difference in constipation after 30 sessions also at the end of treatment (p<0.02, 
p<0.02, respectively).In comparing different grades of complications based on RTOG/ LENT tables, it was 
not observed a significant difference between patients' complications in both arms. 
  
Keywords: clinical complications; conformal radiotherapy; prostate cancer. 
 
INTRODUCTION 
        Three- dimensional conformal 
radiotherapies (3-D CRT) are alternatives rapidly 
conventional procedures to treat prostate cancer. 
The purpose of using CT scans and computer 
designing with more focus on target volume, 
subsequently, transmitting more radiation to 
tumor. Today, MLC for 3-D CRT replaced 
custom block 3D CRT in order to treat prostate 
cancer. There are three strategies using from 
MLC, inbound, outbound and cross bound, 
depending on the location of the treatment, 
treatment technic and sensitivity surrounding 
vital structures used. 
In considering the effect of dose on volume, and 
the incidence of delayed rectal complications by 
3- D CRT, it was found that the more dose in 
rectal volume, the more delayed rectal 
complications, however, the most apparent 
complication was rectal bleeding[1-4]. During 
some reports, it was observed that dosage above 
70Gy to treat prostate cancer with intermediate 
and high risk, their PSA level, before treatment 
was more than PSA>10 mg/ ml, plays a 
significant role in treatment, but a dosage less 
than 70Gy is problematic for such patients [5]. 
Among other studies, we could refer to study of 
comparing 3- D CRT to conventional 
radiotherapy in the treatment of prostate cancer 
in 3 and 6 months following up, it was not 
observed a significant difference among acute 
and delayed complications [6].  
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Also, increasing rectal bleeding in treatment fields 
resulted in reducing delayed complications of 2-4 
grades [7]. 3- D CRT allow higher radiation dosages 
to treat prostate cancer, however, it was shown that 
delayed rectal bleeding is occurred in a special 
threshold of dosage volume proportion [8]. In this 
study, we attempted to consider and compare 
clinical complications of rectum and bladder in 
patients with prostate cancer irradiated by custom 
block and MLC in outbound technique for 3- D 
CRT.  
 
MATERIALS AND METHODS  
      72 patients with prostate cancer above 60 years 
by G4-G9 grades were selected in two 36 members’ 
arms. Patients CT scans and MRIs were fused by 
using treatment planning software; the GTV, CTV 
and PTV were prepared under the supervision of 
physician. All patients provided written 
informed consent for participation. 
 
 
GTV: grow tumor volume. 
CTV: clinical tumor volume. 
PTV: planning tumor volume. 
Patients in first arm were treated by custom block 
and in second arm, by MLC in outbound technique. 
Both arms were treated by linear accelerator 
apparatus. Dosage of every fraction was 1.8- 2 Gy 
and total dosage was in the range of 64-74Gy. 
Patients were 5 days in week and 2 days were rested. 
Data related to patients complications before, during 
(at the end of 10 sessions), after treatment (3-6 
month) were collected and registered. Complications 
were compared, tables and diagrams prepared. 




STATISTICAL ANALYSIS  
      In order to compare patients' complications 
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test, it was determined that the 
percentage of patients with urinary frequency after 
10 sessions in both arms had a significant 
difference (27.8% against 55.6%) (p<0.02); it was 
the same after 3 months of treatment (11.1% 
against 30.6%), (p<0.04). 
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end of treatment had a significant difference 
(44.4% against 19.4%), (p< 0.02). 
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By using Fisher test, it was determined that the 
percentage of patients with constipation after 30 
sessions had a significant difference in both arms 
(5.6% against 27.8%), (p<0.02). It was the same 
at  the end of treatment (11.1% against 31.6%), 
(p<0.02). 
 




Figure 3  Percentage of constipation in participants in both arms 
 
Table 4.distribution and comparison of acute rectal complication grades in participants in both arms, based on RTOG table 
 
Mann- Whitney test didn
'
t show a significant 
difference in the grades of acute rectal 
complications in both arms. 
  
Table 5.  Distribution and comparison of acute bladder complications grades in participants in both arms, based on RTOG 
table. 
 
 total G4 G3 G2 G1 G0 
Acute rectal 
complication 
36 0 1 6 15 14 frequency Block 
Arm 100 0 2.8 16.7 41.6 38.9 percentage 
36 0 1 5 16 14 frequency MLC 
Arm 100 0 2.8 13.9 44.4 38.9 percentage 
- NS NS NS NS NS significant level 
 total G4 G3 G2 G1 G0 
Acute bladder complication 
  
36 0 2 16 16 2 frequency 
Block Arm 
100 0 5.6 44.4 44.4 5.6 percentage 
36 0 1 16 10 9 frequency 
MLC Arm 
100 0 2.8 44.4 27.8 25 percentage 
 - NS NS NS NS NS significant level 




By using Mann- Whitney, it was determined 
that, based on RTOG table, acute bladder 
complication grades had no significant effect in 
both arms. 
  
Table 6.distribution and comparison of delayed rectal complications in participants in both  arms, based on LENT table. 
 
 
total G4 G3 G2 G1 G0 Acute rectal complication 
36 0 0 1 3 32 frequency 
Block Arm 
100 0 0 2.8 8.3 88.9 percentage 
36 0 1 2 4 29 frequency 
MLC Arm 
100 0 2.8 5.6 11.1 8.5 percentage 
- NS NS NS NS NS significant level 
 
Mann- Whitney test didn
'
t show any significant 
difference in the delayed rectal complication 
grades among patients in both arms. 
 
Table 7.distribution and comparison of delayed bladder complication in participants in both arms, based on LENT table. 
total G4 G3 G2 G1 G0 Acute bladder complication 
36 0 2 1 2 31 frequency 
Arm 1 
100 0 5.6 2.8 5.6 86 percentage 
36 0 5 1 4 26 frequency 
Arm 2 
100 0 13.9 2.8 11.1 72.2 percentage 
 - NS NS NS NS NS significant level 
 
Mann- Whitney test didn
'
t show any significant 
difference in various grades of delayed bladder 
complication among patients in both arms. 
 
Table 8.Dose-Volume Histogram 
 
 
ritical structure                                                           Rectum(prostate cancer) 
Custom block Arm 
Total dose 74 Gy 72 Gy 68 Gy 70 Gy 65 Gy 64 Gy 76 Gy 73 Gy 
Mean Dose 41.51Gy 51.57Gy 48.5Gy 47Gy 40.87Gy 37GY 48.12GY 48.22Gy 
Volume V40 V40 V40 V40 V40 V40 V40 V40 
Dose/Volume <46.8% <70% <54% <55% <45% <30% <75% <57% 
Volume V50 V50 V50 V50 V50 V50 V50 V50 
Dose/Volume <47% <70% <47% <46% <36% <23% <36% <43% 
Volume V60 V60 V60 V60 V60 V60 V60 V60 
Dose/Volume <21% <42% <15% <14% <11% <13% <19% <27% 
Volume V65 V65 V65 V65 V65 V65 V65 V65 
Dose/Volume <16% <35% <12% <11% <9% <10% <14% <22% 
Volume V70 V70 V70 V70 V70 V70 V70 V70 
Dose/Volume <11% <17% <8% <7% <5% <4% <9% <17% 
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<33% <65% <67% 
Volume V50 V50 V50 V50 V50 V50 V50 V50 






<30% <48% <56% 
Volume V60 V60 V60 V60 V60 V60 V60 V60 






<14% <23% <42% 
Volume V65 V65 V65 V65 V65 V65 V65 V65 






<12% <15% <14% 
Volume V70 V70 V70 V70 V70 V70 V70 V70 
Dose/Volume <14% <19% 
<10
% <11% <9% <6% <10% 8% 
 
 
DISCUSSION   
     Acute radiotherapy complications have 
affected patients' life quality significantly. Acute 
digestive complications would occur during or 
soon after treatment with such signs as pain and 
irritation, bleeding, constipation, diarrhea, mucus 
effusion, excrement urgency and distress [9, 10]. 
In addition to imposing care costs, acute 
radiotherapy reactions resulted in subsequent late 
complications [11]. Crock et .al research (2001) 
showed that, among 202 patients with prostate 
cancer, totally 25% and 11% had mild and acute 
complications, respectively [12]. Talarli et.al 
(2006) has studied dosage uptake by critical 





Costum Block Arm 
Total dose 74 Gy 72 Gy 68 Gy 70 Gy 65 Gy 64 Gy 76 Gy 73 Gy 
Mean Dose 49 Gy 46 Gy 45 Gy 45 Gy 39 Gy 40 Gy 64 Gy 55 Gy 
Volume V40 V40 V40 V40 V40 V40 V40 V40 
Dose/Volume <73% <71% <70% <70% <63% <63% <75% <69% 
Volume V65 V65 V65 V65 V65 V65 V65 V65 
Dose/Volume <23% <8% <8% <8.5% <9% <11% <30% <29% 




<6% <5% <7% <8.5% <15.5% <11.5% 
MLC Arm 
Total dose 74 Gy 72 Gy 68 Gy 70 Gy 65 Gy 64 Gy 63 Gy 66 Gy 
Mean Dose 52 Gy 50 Gy 47 Gy 50 Gy 42 Gy 43 Gy 41 Gy 45 Gy 
Volume V40 V40 V40 V40 V40 V40 V40 V40 
Dose/Volume <74% <73% <63% <66% <64% <64% <64% <57% 
Volume V65 V65 V65 V65 V65 V65 V65 V65 
Dose/Volume <25.5% <12% <11% <10% <12% <15% <10.5% <13% 
Volume V70 V70 V70 V70 V70 V70 V70 V70 
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3- D CRT. Finally, it was shown that dosage 
uptake by bladder, rectum and femur by MLC 
method was more than custom block [13].  
Robert lee et.al (1996) in one investigation on 
257 patients with prostate cancer treated with 3- 
D CRT has considered the effect of dosage 
volume in the incidence of delayed rectal 
complications. 18 patients showed 2-3 grades 
complications. The most prevalent complications 
were anal bleeding [2]. This research, by 
considering and comparing acute and delayed 
rectal and bladder complications among patients 
in 1 and 2 arm showed that patients had a 
significant difference in urinary frequency 
complication after 10 sessions (27.8% against 
55.6%), (p<0.02), also, 3 months after the 
completion of treatment (11.1% against 30.6%) 
(p<0.04). By comparison of patients in both 
arms, it was determined that they had a 
significant difference in dysuria after completion 
of treatment (44.4% against 19.4%) (p <0.02). 
Comparison of patients in regard to constipation 
complication in both arms showed that, after 30 
sessions, they had significant difference (5.6% 
against 27.8%), (p<0.02). After completion, they 
had significant difference (11.1% against 
36.1%), (p< 0.02).  Sexual dysfunction were 
seen in trifle of patients in both groups which 
may caused by irradiation of penile bulb.    
Anal non-bleeding and reduced bladder 
complications after 6 month of termination of 
radiotherapy course, probably, results from small 





     In summary, here we showed early (Acute) 
complications produced by multileafs method is 
more than custom block method, but in the 
comparison of grades of complications based on 
RTOG/LENT tables, it was not observed a 
significant difference. Answering this question 
needs complementary study that, of both 
treatment methods, which one is preferable in 
regard to incidence of  less clinical complication 
in rectum and bladder. 
“The authors declare no conflict of interest” 
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